nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA5B—Hydrochlorothiazide—nephrolithiasis	0.562	0.59	CbGbCtD
Dobutamine—CA2—Hydrochlorothiazide—nephrolithiasis	0.39	0.41	CbGbCtD
Dobutamine—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00861	0.272	CbGpPWpGaD
Dobutamine—CA2—collecting duct of renal tubule—nephrolithiasis	0.00819	0.523	CbGeAlD
Dobutamine—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.00294	0.093	CbGpPWpGaD
Dobutamine—COMT—Phase II conjugation—SLC26A1—nephrolithiasis	0.00163	0.0517	CbGpPWpGaD
Dobutamine—COMT—nephron tubule—nephrolithiasis	0.00127	0.0808	CbGeAlD
Dobutamine—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00122	0.0386	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00119	0.0378	CbGpPWpGaD
Dobutamine—COMT—renal system—nephrolithiasis	0.00115	0.0735	CbGeAlD
Dobutamine—COMT—kidney—nephrolithiasis	0.00111	0.071	CbGeAlD
Dobutamine—COMT—cortex of kidney—nephrolithiasis	0.00108	0.0692	CbGeAlD
Dobutamine—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00103	0.0325	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.001	0.0317	CbGpPWpGaD
Dobutamine—COMT—Biological oxidations—SLC26A1—nephrolithiasis	0.000956	0.0302	CbGpPWpGaD
Dobutamine—CA2—nephron tubule—nephrolithiasis	0.000787	0.0502	CbGeAlD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000748	0.0237	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000732	0.0232	CbGpPWpGaD
Dobutamine—CA2—renal system—nephrolithiasis	0.000715	0.0456	CbGeAlD
Dobutamine—CA2—kidney—nephrolithiasis	0.000691	0.0441	CbGeAlD
Dobutamine—CA2—cortex of kidney—nephrolithiasis	0.000673	0.043	CbGeAlD
Dobutamine—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00053	0.0168	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GRHPR—nephrolithiasis	0.000389	0.0123	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.000387	0.0122	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.000379	0.012	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000365	0.0116	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GRHPR—nephrolithiasis	0.000363	0.0115	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000357	0.0113	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AGXT—nephrolithiasis	0.000347	0.011	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AGXT—nephrolithiasis	0.000324	0.0103	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—APRT—nephrolithiasis	0.000295	0.00934	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SLC26A1—nephrolithiasis	0.000295	0.00934	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APRT—nephrolithiasis	0.000275	0.00872	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SLC26A1—nephrolithiasis	0.000275	0.00872	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GRHPR—nephrolithiasis	0.000257	0.00815	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000235	0.00745	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00023	0.00729	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AGXT—nephrolithiasis	0.000229	0.00726	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GRHPR—nephrolithiasis	0.000216	0.00683	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AQP1—nephrolithiasis	0.00021	0.00665	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000202	0.00638	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000197	0.00624	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AQP1—nephrolithiasis	0.000196	0.00621	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SLC26A1—nephrolithiasis	0.000195	0.00617	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APRT—nephrolithiasis	0.000195	0.00617	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AGXT—nephrolithiasis	0.000192	0.00608	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CHRM3—nephrolithiasis	0.00019	0.00602	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000178	0.00562	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CHRM3—nephrolithiasis	0.000178	0.00562	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000174	0.0055	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APRT—nephrolithiasis	0.000164	0.00517	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SLC26A1—nephrolithiasis	0.000164	0.00517	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.000161	0.00511	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.000158	0.005	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000154	0.00486	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00015	0.00475	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.000141	0.00445	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AQP1—nephrolithiasis	0.000139	0.0044	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.000137	0.00435	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CHRM3—nephrolithiasis	0.000126	0.00398	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00012	0.0038	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000117	0.00372	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AQP1—nephrolithiasis	0.000117	0.00369	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.000112	0.00355	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00011	0.00347	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.000109	0.00345	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.000107	0.00338	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CHRM3—nephrolithiasis	0.000105	0.00333	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	9.54e-05	0.00302	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	9.33e-05	0.00295	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	8.68e-05	0.00275	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	8.49e-05	0.00269	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	7.94e-05	0.00251	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	7.88e-05	0.00249	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	7.77e-05	0.00246	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	7.71e-05	0.00244	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	7.21e-05	0.00228	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	7.05e-05	0.00223	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	6.44e-05	0.00204	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.44e-05	0.00204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	6.3e-05	0.00199	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.3e-05	0.00199	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	4.66e-05	0.00147	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	4.56e-05	0.00144	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTH—nephrolithiasis	4.26e-05	0.00135	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTH—nephrolithiasis	4.17e-05	0.00132	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	2.14e-05	0.000677	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	2.09e-05	0.000662	CbGpPWpGaD
